Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Published:2021-06 Issue: Volume: Page:
ISSN:2531-1379
Container-title:Hematology, Transfusion and Cell Therapy
language:en
Short-container-title:Hematology, Transfusion and Cell Therapy

Author:

Küçükyurt Selin^ORCID,Kelezoğlu Alihan^ORCID,Elverdi Tuğrul^ORCID,Özmen Deniz,Ar Muhlis Cem,Eşkazan Ahmet Emre^ORCID

Publisher

Elsevier BV

Subject

Hematology,Immunology and Allergy

Reference12 articles.

1. Chronic myeloid leukemia, Version 2.2021, NCCN clinical practice guidelines in oncology;Deininger;J Natl Compr Canc Netw,2020

2. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia;Hochhaus;Leukemia,2020

3. ClinicalTrials. Study of efficacy of CML-CP patients treated with ABL001 versus bosutinib, previously treated with 2 or more TKIs available from: https://clinicaltrials.gov/ct2/show/NCT03106779 [Accessed on November 28, 2020]

4. Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemia;Marchesi;Br J Haematol,2019

5. Clinical characteristics and treatment outcome of patients with isochromosome 17q (i17q) abnormality and myeloid neoplasms: a single center experience;Ganguly;Leuk Res Rep,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP